APA (7th ed.) Citation

E, G., R, S., I, F., K, T., S, O., P, H., . . . S, G. (2026). Humoral IgG1 responses to tumor antigens underpin clinical outcomes in immune checkpoint blockade. Nature medicine, 32(3), 978. https://doi.org/10.1038/s41591-025-04177-6

Chicago Style (17th ed.) Citation

E, Gonzalez-Kozlova, et al. "Humoral IgG1 Responses to Tumor Antigens Underpin Clinical Outcomes in Immune Checkpoint Blockade." Nature Medicine 32, no. 3 (2026): 978. https://doi.org/10.1038/s41591-025-04177-6.

MLA (9th ed.) Citation

E, Gonzalez-Kozlova, et al. "Humoral IgG1 Responses to Tumor Antigens Underpin Clinical Outcomes in Immune Checkpoint Blockade." Nature Medicine, vol. 32, no. 3, 2026, p. 978, https://doi.org/10.1038/s41591-025-04177-6.